Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its neuromodulation platforms for treating chronic pain. The all-cash deal comes ...

a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States. Unraveling the Financial Story of Nevro Market Capitalization Analysis ...

In a report released on February 7, Nathan Treybeck from Wells Fargo maintained a Hold rating on Nevro Corp (NVRO – Research Report), with a price target of $5.85. The company’s shares closed ...

Nevro Corp is a medical device company ... a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.